Pure Global

Application of the Web-based Acceptance and Commitment Therapy for Depression - Trial NCT06293781

Access comprehensive clinical trial information for NCT06293781 through Pure Global AI's free database. This phase not specified trial is sponsored by Gachon University and is currently Recruiting. The study focuses on Major Depressive Disorder. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06293781
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06293781
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Application of the Web-based Acceptance and Commitment Therapy for Depression
The Efficacy and Treatment Mechanisms of the Web-based Acceptance and Commitment Therapy for Patients With Major Depressive Disorder

Study Focus

Major Depressive Disorder

Web-based ACT

Interventional

device

Sponsor & Location

Gachon University

Incheon, South Korea

Timeline & Enrollment

N/A

Dec 19, 2022

Feb 28, 2025

50 participants

Primary Outcome

Acceptance and Action Questionnaire-II

Summary

PROSPECTIVE INTERVENTION STUDY; EFFICACY OF WEB-BASED ACCEPTANCE AND COMMITMENT THERAPY

ICD-10 Classifications

Recurrent depressive disorder
Recurrent depressive disorder, unspecified
Depressive conduct disorder
Other recurrent depressive disorders
Recurrent depressive disorder, current episode moderate

Data Source

ClinicalTrials.gov

NCT06293781

Device Trial